David Zimbalist is a Managing Director in the Healthcare Investment Banking Group, focusing primarily on the life science tools, diagnostics, medical devices, and service spaces sectors.
David has over 25 years of healthcare investment banking and equity research experience, working on a variety of equity, debt and M&A transactions. Prior to joining Janney in 2018, he was a Managing Director at Natixis, most recently as the primary healthcare banker in the Sponsor & Corporate Coverage group. Previously, he led the medical device equity investment banking effort at Natixis Bleichroder. Before moving to investment banking, he spent 13 years in equity research covering medical devices, diagnostics, and life science tools at Schroders, Morgan Stanley, and Natixis Bleichroder.
David received a B.S. in History from the University of Pennsylvania and an M.B.A. from Emory University.